AbbVie to buy drug developer Cerevel for $8.7 billion By Reuters
[ad_1] © Reuters. FILE PHOTO: A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo (Reuters) – AbbVie...
Cerevel options trading surge before AbbVie deal news raises eyebrows By Reuters
[ad_1] © Reuters. FILE PHOTO: Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File...
AbbVie enters agreement to acquire Cerevel Therapeutics By Investing.com
[ad_1] © Reuters AbbVie (ABBV) enters agreement to acquire Cerevel Therapeutics (CERE) AbbVie Inc . (NYSE:) announced Wednesday, alongside Cerevel Therapeutics Holdings Inc (NASDAQ:), that...